Skip to main content
. Author manuscript; available in PMC: 2013 Dec 31.
Published in final edited form as: Cancer Lett. 2012 Feb 19;327(1-2):61–72. doi: 10.1016/j.canlet.2012.02.001

Table 2.

The major steps and protein participants in BER.

BER STEP PROTEIN BIOCHEMICAL ACTIVITY DNA SUBSTRATE
GLYCOSYLASE UNG Glycosylase U
SMUG1 Glycosylase U, hydroxyU, hydroxymethylU
MBD4 Glycosylase U or T opposite G at CpG sites
TDG Glycosylase U, T or ethenoC opposite G
OGG1 Glycosylase, AP β-lyase 8-oxoG opposite C, FAPY
MYH/MUTYH Glycosylase A opposite 8-oxoG
NTH/NTHL1 Glycosylase, AP β-lyase Ring saturated or fragmented Py
MPG Glycosylase 3-MeA, ethenoA, hypoxanthine
NEIL1 Glycosylase, AP β,δ-lyase Tg, FAPY, hydroxyU
NEIL2 Glycosylase, AP β,δ-lyase Oxidized Py
NEIL3 Glycosylase Oxidized Py
AP ENDONUCLEASE APE1 AP endonuclease AP site
STRAND BREAK PROCESSING POLβ 5′-dRP lyase 5′-dRP
APE1 3′-Phosphodiesterase 3′-α,β-Unsaturated aldehyde
PNKP 3′-Phosphatase/5′-Kinase 3′-Phosphate, 5′-hydroxyl
TDP1 3′-Phosphodiesterase 3′-Protein (TopoI)
APRATAXIN 5′-Hydrolase 5′-AMP
POLYMERIZATION POLβ Gap-filling polymerase DNA Gap (1–6 nt)
POLδ (POLε) Strand-displacement polymerase DNA strand break
FEN1 5′-Flap endonuclease 5′-Flap
LIGATION XRCC1/LIG3α Ligase complex DNA nick
LIG1 Ligase DNA nick

AP=apurinic/apyrimidinic; U=uracil; T=thymine; C=cytosine; G=guanine; FAPY=formamidopyrimidine; Py = pyrimidine; dRP = deoxyribose phosphate.

HHS Vulnerability Disclosure